dismiss

Our Clean Sweep Live Auction is coming up fast! Next Tuesday, September 26th at 9:30AM EST

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
当前地点:
>
> This Story


注册记数器 to rate this News Story
Forward Printable StoryPrint Comment

 

MRI Homepage

Dr. Linda Pauliks Miller Children's & Women's Hospital Long Beach name medical director of pediatric & congenital cardiac imaging

Study finds MR detects 98 percent of pregnancy-related breast cancers May also inform surgical management of disease

Radiology Partners to acquire Southwest Diagnostic Imaging Joining with SDI 'represents about a 25 percent increase' in RP's size

Michigan appeals court case could test lay-ownership of MR facility laws Must imaging facilities be owned by doctors?

PET/MR scans can assess pediatric cancer survivor health Study targets chemotherapy after-effects in young patients

New guidelines advise against the use of brain imaging to diagnose chronic pain Researchers continue to look for brain-based biomarkers

FDA approves sale of SyMRI IMAGE software for GE Healthcare MR scanners Reduces scan times

Study finds MR can measure kidney scarring and predict future kidney function Could also test new anti-scarring treatments

Resilience Capital Partners acquires three medical device service and manufacturing companies Forms Innovatus Imaging Corporation

Children’s National Health System first U.S. pediatric institution to use MR-HIFU Requires no incision

FDA panel: Add retention warning to gadolinium contrast agents

Thomas Dworetzky , Contributing Reporter
The gadolinium safety debate took another turn Friday, when the FDA's Medical Imaging Drugs Advisory Committee (MIDAC) voted to recommend revisions to the prescribing information for MR contrast agents with the material.

The vote was to add a warning that gadolinium can be retained in some organs and tissues.

Story Continues Below Advertisement

The (#1 Resource) for Medical Imaging and Peripherals. Call 1-949-273-8000

As a Master Distributor for major brands Barco, Philips, and Sony, we offer custom imaging solutions. With our renowned OEM Solutions and Service/Repair Center, Ampronix is a one-stop shop for HD Medical LCD Displays--Printers--Recorders--4K Cameras



According to a response to the meeting by Guerbet, “There are two kinds of gadolinium based contrast agents [GBCAs], linear and macrocyclic. Although there are many similarities amongst these agents, they differ in their kinetic and thermodynamic stability. Linear GBCAs are generally less stable, and for this reason, more likely than macrocyclic agents to deposit gadolinium in tissue. Guerbet's GBCA, Dotarem [gadoterate meglumine] is a macrocyclic agent. The advisory would also state the risk of retention is slightly greater with linear agents versus macrocyclic ones.”

At the meeting, 13 committee members voted in favor of the proposal. "It was appropriate to state that there may be differences among these agents that need to be explored," said one, Dr. Michael Weisman, a professor of medicine at the University of California, Los Angeles, adding that, "It's also appropriate to state that risk strategies need to be looked at more carefully. There are populations that need to be addressed, such as those that may overutilize this type of contrast imaging."

The strongest – and only – dissenting vote came from Alicia Toledano, who is president of Biostatistics Consulting in Kensington, MD. She felt it did not go far enough.

"It is hard to dismiss an anecdotal report when you are the anecdote. A life ruined is a life ruined," she said. "What does a patient do when doctors and everyone she or he turns to for help 'pooh-poohs' his or her concerns and does not order a simple urine test? When a patient finally gets tested and is found to have gadolinium retention, there is no FDA-approved antidote. What does that patient do?"

She called the proposal “insufficient.”



The group was also unanimous at 15-0 in its vote requiring the agency to have contrast manufacturers do more studies to see if more regulation is necessary.

The group argued that more information is vital.

"It's clear we need more information," stated Dr. Peter Herscovitch, acting MIDAC chair and director of the PET department at the U.S. National Institutes of Health (NIH).

The votes followed a public hearing on retention that saw many emotional moments about adverse reactions, including from a representative of Gena Norris, the wife of famed action-star Chuck Norris. After a series of scans with gadolinium, she suffered severe abdominal pain.

She has resorted to treating her condition with an expensive professional hyperbaric chamber.

"My heart breaks for those who don't have the financial means they need," she added. "We will continue to use our platform to raise awareness about the dangers of gadolinium."

That said, despite the risks of retention, Dr. Elizabeth Morris, past president of the Society of Breast Imaging and a breast radiologist at Memorial Sloan Kettering Cancer Center, called its use essential and a “lifesaving test."

Also advising caution against an overreaction, Dr. Scott Reeder, of the University of Wisconsin, advised that, "it is important to consider the importance of the benefits of gadolinium in treating patients with a wide variety of diseases, as well as the standard safety record of these agents."

MRI Homepage


You Must Be Logged In To Post A Comment

做广告
提升您的品牌知名度
拍卖+私人销售
获得最好的价格
买设备/配件
找到最低价格
每日新闻
阅读最新信息
目录
浏览所有的DOTmed用户
DOTmed上的伦理
查看我们的伦理计划
金子分开供营商节目
接收PH要求
金子服务经销商节目
接收请求
提供保健服务者
查看所有的HCP(简称医疗保健提供商)的工具
工作/训练
查找/申请工作
Parts Hunter +EasyPay
获取配件报价
最近证明
查看最近通过认证的用户
最近额定
查看最近通过认证的用户
出租中央
租用设备优惠
卖设备/配件
得到最划算
服务技术员论坛
查找帮助和建议
简单的征求建议书
获取设备报价
真正商业展览
查找对设备的服务
对这个站点的通入和用途是受期限和条件我们支配 法律公告 & 保密性通知
物产和业主对 DOTmed.com,公司 Copyright ©2001-2017 DOTmed.com, Inc.
版权所有